NCT02678884Completed
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
A Pilot Study of 18F-FDG PET-CT Kinetic Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to see how useful the information provided from Positron Emission Tomography (PET) scans can be in the actual planning and delivery of radiation treatment to patients who have head and neck cancers. Patients participating in this study, will have (in addition to their routine tests) a PET scan before and during their radiation treatment. Following the intervention, patients will be followed as per standard practice.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 19 (actual)
- First submitted
- 27 Nov 2014
- Start date
- Oct 2014
- Primary completion date
- 13 Jan 2025
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Head and neck cancer
- NCT number
- NCT02678884
What you commit to
- Study type: Interventional
- Participants enrolled: 19
- From Oct 2014 to the primary completion date, 13 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior head and neck radiotherapy
Other illness
- Nasopharynx cancer
- Prior malignancy within the last 5 years (exclude non-H\&N SCC, BCC skin)
Lab values
- Prior chemotherapy within the last 5 years or concurrent chemotherapy/EGFR inhibitors
Other
- H\&N SCC skin
- Distant metastases (already known or if found on baseline CT-thorax)
- Inability to lie supine for study duration
- Pregnancy
- Inability to provide informed consent
Who the study is looking for
- Non-nasopharynx head and neck mucosal squamous cell carcinoma
- Radiologically evident gross disease
- Radiotherapy alone for curative intent
- Age equal to or more than 18 years old
- To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Health Network - Princess Margaret Cancer Center Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.